Jaguar8 commented on a stock · Nov 27, 2024 02:29

NEWS

iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership with Cascaid Health at RSNA 2024

iCAD announces major developments at RSNA 2024, including its FDA-cleared ProFound Detection Version 4.0 and a partnership with Cascaid Health.

The collaboration will launch ProFound Health in Q1 2025, offering AI-powered second-read mammography services to expand access to breast health technology. The new Version 4.0 improves aggressive cancer detection by 22% and reduces no-mark cases by 18%.

Clinical data shows significant improvements, including a 23% increase in cancer detection rates and 32% enhanced detection in dense breast tissue.

The company will showcase these innovations at RSNA 2024 in Chicago, December 1-5, featuring presentations on real-world AI implementation results and technical advances.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

4399 Views

Comment

Jaguar8

Spread kindness and love. Life is short. Don’t let greed eat you.

8218

Followers

Following

94K

Visitors